Mahesh Bajaj
Springfield, MANPI 1649247537
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 389 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,219 and has fallen 93.9% since, to $136 in 2023.
Across 389 payments — averaging $19.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$1K
- Sanofi$737
- CSL Behring$630
- Novartis$615
- Takeda Pharmaceuticals U.S.A., Inc.$300
- plus $2K from 19 others
What the payments were for
- Food & beverage$7,40298%
- Education$1272%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 75 | $1,574 |
| GSK | 79 | $1,489 |
| Sanofi | 36 | $737 |
| CSL Behring | 30 | $630 |
| Novartis | 43 | $615 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $300 |
| Regeneron Healthcare Solutions, Inc. | 16 | $287 |
| Grifols USA, LLC | 15 | $272 |
| Amgen | 15 | $266 |
| Boehringer Ingelheim | 15 | $253 |
| Pharming Healthcare, Inc. | 8 | $160 |
| Sanofi-aventis U.S. LLC | 4 | $150 |
| Optinose US, Inc. | 7 | $135 |
| Octapharma USA, Inc. | 6 | $127 |
| Kaleo, Inc. | 5 | $103 |
| Genentech USA, Inc. | 5 | $99 |
| Teva Pharmaceuticals USA, Inc. | 5 | $87 |
| Covis Pharma GmbH | 3 | $63 |
| Shire North American Group Inc | 3 | $50 |
| Merck | 2 | $36 |
| LEO Pharma Inc. | 1 | $26 |
| Biocryst US Sales Co., LLC | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| Alk-abello, Inc | 1 | $16 |
| Hikma Pharmaceuticals USA | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FASENRA$125
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.